LSV Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.19M Sell
133,300
-32,000
-19% -$1.35M 0.01% 523
2026
Q1
$9.14M Sell
165,300
-14,400
-8% -$685K 0.02% 405
2025
Q4
$6.71M Sell
179,700
-24,000
-12% -$975K 0.01% 436
2025
Q3
$8.24M Sell
203,700
-19,700
-9% -$651K 0.02% 421
2025
Q2
$5.71M Buy
223,400
+40,800
+22% +$890K 0.01% 457
2025
Q1
$3.9M Buy
182,600
+89,700
+97% +$2M 0.01% 503
2024
Q4
$1.95M Sell
92,900
-15,500
-14% -$359K ﹤0.01% 557
2024
Q3
$2.44M Hold
108,400
0.01% 562
2024
Q2
$1.82M Hold
108,400
﹤0.01% 615
2024
Q1
$1.4M Hold
108,400
﹤0.01% 649
2023
Q4
$1.25M Sell
108,400
-6,900
-6% -$77.9K ﹤0.01% 667
2023
Q3
$1.47M Sell
115,300
-22,900
-17% -$325K ﹤0.01% 647
2023
Q2
$1.89M Buy
138,200
+52,600
+61% +$754K ﹤0.01% 630
2023
Q1
$1.31M Sell
85,600
-9,300
-10% -$142K ﹤0.01% 644
2022
Q4
$1.27M Hold
94,900
﹤0.01% 634
2022
Q3
$1.26M Buy
94,900
+142
+0.1% +$2.45K ﹤0.01% 627
2022
Q2
$1.81M Buy
94,758
+15,358
+19% +$291K ﹤0.01% 620
2022
Q1
$1.58M Buy
79,400
+6,200
+8% +$125K ﹤0.01% 658
2021
Q4
$1.5M Buy
73,200
+21,300
+41% +$455K ﹤0.01% 674
2021
Q3
$1.12M Hold
51,900
﹤0.01% 702
2021
Q2
$1.5M Buy
51,900
+6,292
+14% +$170K ﹤0.01% 679
2021
Q1
$1.11M Buy
+45,608
New +$1.03M ﹤0.01% 717

Other funds holding PAHC

LSV Asset Management's PAHC Position: Q2 2026 in Review

LSV Asset Management reduced its Phibro Animal Health (PAHC) stake by 19% in Q2 2026, selling an estimated $1.35M and leaving 133,300 shares worth $4.19M. The position accounts for 0.01% of the portfolio, ranked #523.

LSV Asset Management first reported a position in PAHC in Q1 2021 and has held it in 22 quarters since. The position peaked at $9.14M in Q1 2026. 78 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • LSV Asset Management held 133,300 shares of Phibro Animal Health worth $4.19M as of Q2 2026.
  • LSV Asset Management sold 32,000 Phibro Animal Health shares in Q2 2026, an estimated $1.35M.
  • Phibro Animal Health made up 0.01% of LSV Asset Management's portfolio in Q2 2026, its #523 holding.
  • LSV Asset Management first reported a position in Phibro Animal Health in Q1 2021 and has held it in 22 quarters since.
  • LSV Asset Management's Phibro Animal Health position peaked at $9.14M in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.